Anteris Technologies Ltd (AVR.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 03:59PM AEST
| Previous close | 21.30 |
| Open | 21.70 |
| Bid | 21.29 x 60900 |
| Ask | 21.60 x 237300 |
| Day's range | 21.16 - 21.70 |
| 52-week range | 15.58 - 24.38 |
| Volume | |
| Avg. volume | 17,167 |
| Market cap | 408.987M |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.31 |
| Earnings date | 18 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 30.00 |
Simply Wall St.Those who invested in Anteris Technologies (ASX:AVR) five years ago are up 292%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...
Simply Wall St.Anteris Technologies Full Year 2023 Earnings: Misses Expectations
Anteris Technologies ( ASX:AVR ) Full Year 2023 Results Key Financial Results Revenue: AU$4.11m (down 10% from FY...
Business WireAnteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023
BRISBANE, Australia & MINNEAPOLIS, September 12, 2023--Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing the world’s only balloon-expandable, single-piece transcatheter aortic valve (TAVR) for the treatment of aortic stenosis announced today that Wayne Paterson, the Chief Executive Officer of Anteris will present at the Cantor Fitzgerald Annual Global Healthcare Conference in New York, NY on Tuesday, September 26, 2023, at 2:45 p.m. Eastern Time.
© 2024 Yahoo. All rights reserved.